1. Catalog
  2. 2025 Asia Conference on Lung Cancer (ACLC) - On-De ...
2025 Asia Conference on Lung Cancer (ACLC) - On-Demand Access
(2)
Conference | English | 2025
Create Account
Cost
Free: $0.00
Regular Member: $200.00
Member - Other: $150.00
Associate: $0.00
Associate - Other: $0.00
Associate - Developing Country: $0.00
Member - Developing Country: $150.00
Non-Member - Developing Country: $200.00
Non-Member: $250.00
Credit Offered
No Credit Offered

This product is:

  • Available for purchase for those that did NOT attend the conference

For questions, email education@iasl.org.

Due to technical issues, the recordings are not available at this time. You may still access the content to download the presentation slides for each session.

The IASLC Asia Conference on Lung Cancer (ACLC), October 9-11, 2025 in Ho Chi Minh, Vietnam, will address key regional challenges, including the high prevalence of genetic mutations, environmental risk factors, and disparities in healthcare access. The conference will focus on expanding early detection through low-dose CT and AI, advancing biomarker testing, and fostering multidisciplinary collaboration among medical oncologists, surgeons, radiologists, pulmonologists, radiation oncologists, pathologists, and all healthcare providers involved in the care of patients with thoracic malignancies. Sessions will explore strategies to improve access to targeted therapies, immunotherapy, and innovative surgical and radiotherapy techniques. Additionally, discussions will highlight public health initiatives, tobacco control, and approaches to reduce healthcare disparities. Education, training, and patient advocacy will remain central themes, ensuring a sustainable and patient-centered approach to lung cancer care across Asia.

The conference is designed to meet the educational needs of researchers and healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists, advanced practice nurses and physician assistants.
Upon completion of this activity, the participants should be able to: 
  • Examine scientific advances in thoracic cancer to make evidence-based diagnosis and treatment decisions.
  • Synthesize cutting edge research from clinical trials and translational studies to deepen knowledge within primary specialty area(s) and broaden knowledge of other specialties.
  • Support lung cancer prevention strategies including tobacco control, smoking cessation, reducing environmental risks, addressing the quality and value of healthcare, and implementing early screening.
  • Apply evidence-based recommendations and clinical practice guidelines to diagnose and manage patients.
  • Employ multidisciplinary teams to improve patient outcomes through patient-centered diagnostic, therapeutic and palliative care.
  • Support and empower patients to become active participants in their treatment.  
Program Co-Chairs:
  • Ying Chen, MD In Memoriam 
  • Wendy Cooper, PhD, MB, FRCPA
  • Tu Dao, MD, PhD, FACP
  • Feng-Ming (Spring) Kong, MD, PhD
  • Jin Mo Goo, MD, PhD
  • Ayumi Suzuki, MD, PhD
The information presented is that of the contributing faculty and does not necessarily represent the views of the International Association for the Study of Lung Cancer and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse effects.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Accreditation Statement: 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Association for the Study of Lung Cancer is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statements:

Physicians
The International Association for the Study of Lung Cancer designates the “other activity” (a live conference offered in a hybrid format including recorded virtual participation) format for this educational activity for a maximum of 7 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Registered Nurses
For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education).

Physician Associates
The National Commission on Certification of Physician Assistants (NCCPA) states that the AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification.

Hong Kong College of Radiologists Credit for Fellows 

  1. Fellows can apply at the time when submitting the CME/CPD Log Sheet at the end of the year for attending ACLC 

Add the meeting to the log sheet provided by the HKCR and submit the log to the CME/CPD Sub-Committee at the end of the year along with documentation of attendance of activity such as a certificate of attendance with a detailed program. 

  1. Fellows can apply right after attending ACLC 

Fellows can submit the completed “CME/CPD Application Form for Local/Overseas Educational Activities” (which can be downloaded from the HKCR website) at https://link.edgepilot.com/s/f8c1bdc3/8laW4ZXDK0_4WnAI9juWOA?u=https://hkcr.org/forms.php/forms), together with the documentation of attendance of activity such as certificate of attendance with a detailed program. 


Countries that accept ACCME-accredited continuing medical education (CME):
The below list includes countries that accept ACCME-accredited continuing medical education (CME). Please note that some countries that accept ACCME-accredited education do not have specific credit requirements for their physicians. 

Antigua & Barbuda
Regulator: Antigua & Barbuda Medical Council

Austria
Regulator: Austrian Academy of Physicians on behalf of the Austrian Medical Chamber

Bahamas
Regulator: Bahamas Medical Council

Belgium
Regulator: Group of Belgian Professional Unions of Specialist Doctors

Bhutan
Regulator: Medical and Health Professional Council, Royal Government of Bhutan

Canada
Regulator: Royal College of Physicians and Surgeons of Canada Maintenance of Certification Program

Croatia
Regulator: Croatian Medical Chamber

Gambia, The
Regulator: The Medical and Dental Council of the Gambia

Germany
Regulator: State Chambers of Physicians in the 16 federal states (only in-person, live events)

India, State of Punjab
Regulator: Punjab Medical Council

Israel
Regulator: Scientific Council, Israeli Medical Association

Jamaica
Regulator: Medical Council of Jamaica

Kuwait
Regulator: Professional Licensing - Ministry of Health

Malawi
Regulator: Medical Council of Malawi

Netherlands, The
Regulator: Royal Dutch Society of the Promotion of Medicine

Oman
Regulator: Oman Medical Specialty Board

Qatar
Regulator: Accreditation Section of the Department of Healthcare Professions of the Qatar Ministry of Public Health

Rwanda
Regulator: Rwanda Medical & Dental Council

Saudi Arabia
Regulator: Saudi Commission for Health Specialties

Singapore
Regulator: Singapore Medical Council

South Africa
Regulator: Health Professions Council of South Africa

Spain
Regulator: Spanish Medical Professional Accreditation Council for CPD/CME

Sri Lanka
Regulator: Sri Lanka Medical Council, Sri Lanka Medical Association, and the Ministry of Health

Sweden
Regulator: Swedish Medical Association

Trinidad & Tobago
Regulator: The Trinidad and Tobago Medical Association

Turkey
Regulator: Turkish Medical Association CME-CPD Accreditation Council

United Arab Emirates, Abu Dhabi
Regulator: Department of Health

United Arab Emirates, Dubai
Regulator: Dubai Health Authority
If you need assistance with this activity, please email: education@iaslc.org. 
Powered By